INSP vs. SOLV, SNN, PEN, STVN, GKOS, BLCO, NARI, IRTC, PRCT, and NVST
Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.
Inspire Medical Systems vs.
Solventum (NYSE:SOLV) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.
94.9% of Inspire Medical Systems shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Inspire Medical Systems has a net margin of 6.67% compared to Solventum's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Solventum's return on equity.
Inspire Medical Systems received 192 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.66% of users gave Inspire Medical Systems an outperform vote while only 4.17% of users gave Solventum an outperform vote.
Solventum has higher revenue and earnings than Inspire Medical Systems. Solventum is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
In the previous week, Solventum had 23 more articles in the media than Inspire Medical Systems. MarketBeat recorded 25 mentions for Solventum and 2 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.51 beat Solventum's score of 0.85 indicating that Inspire Medical Systems is being referred to more favorably in the news media.
Solventum presently has a consensus target price of $79.86, indicating a potential upside of 7.56%. Inspire Medical Systems has a consensus target price of $228.82, indicating a potential upside of 33.90%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Solventum.
Summary
Inspire Medical Systems beats Solventum on 13 of the 17 factors compared between the two stocks.
Get Inspire Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspire Medical Systems Competitors List
Related Companies and Tools
This page (NYSE:INSP) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy INSP Stock Free INSP Stock Alerts